Blum, Jacob A.
Klemm, Sandy
Shadrach, Jennifer L.
Guttenplan, Kevin A. http://orcid.org/0000-0003-4242-4349
Nakayama, Lisa
Kathiria, Arwa
Hoang, Phuong T.
Gautier, Olivia
Kaltschmidt, Julia A.
Greenleaf, William J. http://orcid.org/0000-0003-1409-3095
Gitler, Aaron D. http://orcid.org/0000-0001-8603-1526
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R35NS097263, R01NS083998)
Article History
Received: 4 October 2020
Accepted: 23 December 2020
First Online: 15 February 2021
Competing interests
: A.D.G. has served as a consultant for Aquinnah Pharmaceuticals, Prevail Therapeutics and Third Rock Ventures and is a scientific founder of Maze Therapeutics. W.J.G. has affiliations with 10x Genomics (consultant), Guardant Health (consultant) and Protillion Biosciences (co-founder and consultant). J.A.B. has served as a consultant for Maze Therapeutics.